How does ruxolitinib/ruxolitinib cream treat vitiligo?
Vitiligo is a skin disease caused by an abnormality in the immune system and manifests as patches of lack of pigment on the skin. In recent years, with the advancement of medical research, the treatment options for vitiligo have gradually become diversified. Ruxolitinib cream (Ruxolitinib), as a targeted JAK inhibitor, has been proven to have certain efficacy in the treatment of vitiligo.
The mechanism of action of ruxolitinib cream is mainly by inhibitingJAK1 and JAK2 kinases, regulating the immune system and reducing the attack of overactive immune cells on skin melanocytes. This inhibitory effect can effectively prevent the immune system from damaging the skin, thereby promoting the recovery of melanocytes and helping the patient's skin color gradually return to normal.

Clinical studies have shown that ruxolitinib cream is particularly effective in patients with moderate to severe vitiligo. After using ruxolitinib cream, most patients' white spot areas were effectively reduced, and some patients' skin pigment was significantly restored. Because the drug is administered locally, it has relatively fewer side effects than systemic treatments. Patients generally do not experience severe systemic reactions during use, making ruxolitinib cream the treatment of choice for many patients.
It should be noted that ruxolitinib cream is not a universal treatment option for all patients with vitiligo. Its efficacy is affected by many factors, including the severity of the patient's condition, the timing of drug use, and individual differences among patients. For patients with early-stage vitiligo, ruxolitinib cream may be able to effectively control the condition, but for patients with a longer course of disease and larger white spots, the efficacy may be relatively limited.
Although ruxolitinib cream shows good promise in treating vitiligo, patients still need to fully communicate with their doctors before using it to understand its indications, treatment options and possible side effects to ensure the safety and effectiveness of the treatment.
Reference: https://www.opzelura.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)